FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/10/037470 [Registered on: 22/10/2021] Trial Registered Prospectively
Last Modified On: 16/10/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Clinical Study of a AVI- TR 01 ointment in Patients with arthritis of knee and low back ache. 
Scientific Title of Study   A parallel arm interventional Clinical Study to Assess the Efficacy and Tolerability of a AVI- TR 01 ointment in Patients with chronic osteoarthritis of knee and low back ache. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
MHC/CT/21-22/001 Ver.1. dated 6 April 2021  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Umesh Gajare 
Designation  Consultant 
Affiliation  Jyoti Clinic and Research Centre 
Address  OPD 1 Ground floor B 3 Saipritam kaliwadi Rahatni link Road Kalewadi Pune MAHARASHTRA India

Pune
MAHARASHTRA
411017
India 
Phone  8796739140  
Fax    
Email  dr.gajareumesh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Gayatri Ganu 
Designation  Managing Director 
Affiliation  Mprex Healthcare Pvt. Ltd. 
Address  501 Crossroads Wakad Pune MAHARASHTRA India

Pune
MAHARASHTRA
411057
India 
Phone  8554912644  
Fax    
Email  gayatri.mbgindia@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Mr Ashish Nagaonkar 
Designation  Partner 
Affiliation  M.N.Pharmaceuticals 
Address  27 Madhumansion Old P B Road NIPANI Belgaum KARNATAKA India

Belgaum
KARNATAKA
591237
India 
Phone  7892647421  
Fax    
Email  pharmaceuticals.m.n@gmail.com  
 
Source of Monetary or Material Support  
MN Pharmaceuticals, R S NO 51 1B KLE CBSE CORNER BUDALMUKH ROAD NIPANI 
 
Primary Sponsor  
Name  MN Pharmaceuticals 
Address  R S NO 51 1B KLE CBSE CORNER BUDALMUKH ROAD NIPANI 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Umesh Gajare  Jyoti clinic and research center  OPD 1, Ground floor, B3 Sai Pritam, Kalewadi, rahatani link road, Kalewadi
Pune
MAHARASHTRA 
8796739140

dr.gajareumesh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Lokmanya Medical Research Center  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M190||Primary osteoarthritis of other joints. Ayurveda Condition: Sandhivat,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  AVI- TR 01 ointment  Apply sufficient amount to the affected area and massage gently. Do not rub. For topical use only. 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Male and female subjects aged 30 to 65 years
Patients with back pain for at least 3-6 months with score on VAS more than or equal to 4
Patients with Knee pain for at least 3-6 months with score on VAS more than or equal to 4
Suffering from joint discomfort for at least 3 months duration
Subjects agreeing to discontinue any use of analgesics during the study.
Ready to provide written informed consent
Willing to come for the follow-up visits for evaluation
 
 
ExclusionCriteria 
Details  Surgery for low back pain/ knee joint pain in the last 6 months or planning for surgical intervention during the course of the study.
Sensitive skin and damaged/ broken skin at the application site.
Secondary OA, such as due to injury, inflammatory condition, metabolic or rheumatic disease, osteonecrosis, Paget’s disease, hemophilia etc.
Presence of any severe medical or psychological condition
Patients participated in another clinical drug trial within 3 months before recruitment in this trial
Any other medical condition that in the Investigators opinion would preclude patient participation
Subjects with past history of addiction abuse and rehabilitation
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Changes in pain score with VAS
Changes in WOMAC score
Changes in severity of other symptoms like swelling, tenderness
 
Baseline, Day 7 and Day 14 
 
Secondary Outcome  
Outcome  TimePoints 
Assessment of quality of life (QoL)
Changes in in requirement of analgesics as a rescue medication
Assessment of patient compliance
Assessment of study product tolerability
Adverse events/ Adverse drug reactions
 
Baseline, Day 7 and Day 14 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   30/10/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="14" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The present study is to clinically validate the effectiveness of AVI- TR 01 ointment in subjects suffering from osteoarthritis of knee and low back ache

 
Close